Latest news with #marketanalysis
Yahoo
2 hours ago
- Business
- Yahoo
July rate cuts would be 'quite premature': Fmr. Fed official
Federal Reserve governor Chris Waller signaled that the central bank could cut rates at its July meeting, CNBC reported. Mercatus Center senior-affiliated scholar and former Richmond Fed president Jeffrey Lacker joins Market Domination to share his read of the possibility of a July cut. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. Sign in to access your portfolio
Washington Post
20 hours ago
- Business
- Washington Post
Asian shares are mixed and oil gains as world waits to see if US will join Israel's war against Iran
MANILA, Philippines — Crude oil prices rose and Asian shares were trading mixed on Friday as investors awaited more clarity on whether or not the U.S. will join Israel's war against Iran. U.S. futures edged lower after Wall Street was closed on Thursday for the Juneteenth holiday. U.S. benchmark crude oil added 15 cents to $73.65 per barrel, while Brent crude, the international standard was up 19 cents at $76.89 per barrel. Oil prices have been gyrating as fears rise and ebb that the conflict between Israel and Iran could disrupt the global flow of crude. Iran is a major producer of oil and also sits on the narrow Strait of Hormuz, through which much of the world's crude passes. Investors remained wary after the White House said President Donald Trump could decide on whether to launch an attack on Israel within the next two weeks , but that he 'still believes diplomacy is an option,' said Anderson Alves, a trader at ActivTrades. Trump's tariffs agenda remains another major factor weighing on markets. Tokyo's Nikkei 225 index edged 0.1% higher to 38,538.14 after Japan reported that its core inflation rate, excluding volatile food prices, rose to 3.7% in May, adding to challenges for Prime Minister Shigeru Ishiba's government and the central bank. 'Core Japanese inflation rose more than expected in May. Even so, the Bank of Japan is likely to prioritize the negative impact of U.S. tariffs, Min Joo Kang of ING Economics said in a commentary. 'For now, it's more concerned about the risk that US trade policies could break the virtuous circle of wage growth and inflation.' Hong Kong's Hang Seng index jumped 1.2% to 23,504.59, while the Shanghai Composite gained 0.1%, reversing earlier losses, to 3,364.83. China's central bank kept its key 1-year and 5-year loan prime rates unchanged, as expected. Australia's S&P/ASX 200 shed 0.3% to 8,500.40 while South Korea's Kospi gained 1.2% to 3,014.05. 'Risk sentiments were cautious as Iran-Israel tensions continued roiling,' Mizuho Bank Ltd. said in a commentary. On Thursday, the Bank of England kept its main interest rate at a two-year low of 4.25%, citing risks that the conflict between Israel and Iran will escalate. The U.S. dollar slipped to 145.28 Japanese yen from 145.46 yen. The euro rose to $1.1530 from $1.1498.
Yahoo
a day ago
- Business
- Yahoo
Hyaluronic Acid Market Projected to Reach USD 18.53 Billion by 2032, Driven by Aesthetic Advancements and Expanding Clinical Applications
SNS Insider Unveils Strategic Insights into the U.S. Hyaluronic Acid Market's Rise—Forecast to Hit USD 6.56 Billion by 2032—Powered by Non-Invasive Aesthetic Trends and Medical Innovations. Austin, June 19, 2025 (GLOBE NEWSWIRE) -- Hyaluronic Acid Market Size & Growth Analysis 'According to SNS Insider, the Hyaluronic Acid Market was valued at USD 10.90 billion in 2024 and is expected to reach USD 18.53 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.92% over the forecast period 2025-2032.' The global hyaluronic acid market is witnessing steady expansion, fueled by its broad application across dermatology, orthopedics, ophthalmology, and drug delivery systems. HA's unique properties—including biocompatibility, viscoelasticity, and hydrating capabilities—have made it essential for both therapeutic and aesthetic use cases. Consumer awareness of non-invasive cosmetic procedures and the rising demand for anti-aging products continue to drive growth, particularly within the cosmetic a Sample Report of Hyaluronic Acid Market@ In the United States, the hyaluronic acid market was valued at USD 3.95 billion in 2023 and is forecasted to reach USD 6.56 billion by 2032. The strong presence of aesthetic service providers, continued advancements in technology, and growing preference for FDA-approved injectable treatments are supporting this growth. Additionally, increasing utilization of HA in ophthalmic and orthopedic treatments further positions the U.S. as a leading market. Major Players Analysis Listed in this Report are: Zimmer Biomet Smith & Nephew Plc Shiseido Company, Limited Sanofi Salix Pharmaceuticals Maruha Nichiro, Inc. Lifecore Biomedical, Llc LG Life Sciences Ltd (LG Chem.) HTL Biotechnology Genzyme Corporation Galderma Laboratories L.P. Ferring B.V. F. Hoffmann-La Roche Ag Bloomage Biotechnology Corporation Limited Allergan Hyaluronic Acid Market Report Scope Report Attributes Details Market Size in 2024 USD 10.90 billion Market Size by 2032 USD 18.53 billion CAGR (2025–2032) 6.92% U.S. Market 2024 USD 3.95 billion U.S. Forecast by 2032 USD 6.56 billion Base Year 2024 Forecast Period 2025–2032 Key Regional Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Segment Analysis By Product: Multiple injection doses dominated the market share in 2024 with a share of 78.54%, as they effectively treat chronic joint disorders and aesthetic treatment requiring regular interval doses. Dermatologists and Orthopedic doctors frequently use these products because their effects persist over time, and the patients appear in good health. On the other hand, the best-performing category is single-injection dose, for the convenience and the minimization of exposure to the clinic, continuing to grow at the fastest pace. Such formulations are being adopted in orthopaedics for the management of early-stage osteoarthritis due to rapid onset and enhanced compliance. By Application: The dermal fillers application was the largest market in 2023, as the segment accounted for 42.36% of the total market, due to the substantial consumer base for minimally invasive beauty procedures. The demand for dermal fillers prepared from HA used for facial remodeling, correction of wrinkles, and increase of lip volume has increased, and the reasons can be found in the shorter recovery period and the instant effect of the product. The ophthalmic segment, by contrast, is projected to register the most rapid growth, driven chiefly by the rising prevalence of eye surgeries such as cataract extraction, for which HA is administered during intraocular procedures to prevent injury to vulnerable eye tissues and preserve ocular pressure. By Grade: In terms of grade, pharmaceutical-grade hyaluronic acid led the market in 2023 with a commanding 71.25% share. This is attributed to its application in prescription-based products and its higher regulatory compliance standards. The superior purity and safety of pharmaceutical-grade HA make it suitable for intra-articular injections, ophthalmic surgeries, and drug formulations, driving its widespread adoption across medical disciplines. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Hyaluronic Acid Market Segmentation By Product Multiple injection doses Single injection dose By Application Dermal fillers Osteoarthritis Ophthalmic Vesicoureteral reflux Other applications By Grade Cosmetic grade hyaluronic acid Pharmaceutical grade hyaluronic acid By End-Use Hospitals Dermatology clinics Ambulatory surgical centers Other end-users Regional Analysis North America was the dominant region in the hyaluronic acid market in 2023, holding 44.07% market share. Enhanced healthcare infrastructure and aesthetic awareness, along with good disposable income vital for the region. Rigorous regulatory guidelines and high adoption of HA-based dermal fillers further contribute to its dominance. The APAC region is experiencing the maximum growth due to rising disposable income, aging population, and rising trend of cosmetic surgeries in countries like Japan, South Korea, and China. KCEAC PTE LTD 35 In addition, government expenditure on healthcare and the development of medical tourism drive demand in the region. Recent Developments March 2024 – Allergan Aesthetics, an AbbVie company, underscored its continued commitment to innovation in medical dermatology and aesthetics at the AAD Annual Meeting in San Diego with 29 abstracts on display at the meeting. May 2024 – Anika Therapeutics introduced Hyaff, a novel HA-based solid product platform for joint and tissue repair. Buy a Single-User PDF of Hyaluronic Acid Market Analysis & Outlook Report 2024-2032@ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Hyaluronic Acid Market by Product 8. Hyaluronic Acid Market by Application 9. Hyaluronic Acid Market by Grade 10. Hyaluronic Acid Market by End-Use 11. Regional Analysis 12. Company Profiles 13. Use Cases and Best Practices 14. Conclusion About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
Global Dividend Stocks To Watch In June 2025
As global markets navigate the complexities of escalating Middle East tensions and fluctuating trade dynamics, investors are keenly observing how these factors impact stock indices worldwide. In such a volatile environment, dividend stocks can offer a measure of stability and income, making them an attractive option for those seeking to mitigate risk while maintaining potential returns. Name Dividend Yield Dividend Rating Yamato Kogyo (TSE:5444) 4.56% ★★★★★★ NCD (TSE:4783) 4.16% ★★★★★★ Japan Excellent (TSE:8987) 4.29% ★★★★★★ GakkyushaLtd (TSE:9769) 4.62% ★★★★★★ DoshishaLtd (TSE:7483) 4.10% ★★★★★★ Daito Trust ConstructionLtd (TSE:1878) 4.30% ★★★★★★ Daicel (TSE:4202) 5.02% ★★★★★★ CAC Holdings (TSE:4725) 4.84% ★★★★★★ Banque Cantonale Vaudoise (SWX:BCVN) 4.93% ★★★★★★ Allianz (XTRA:ALV) 4.56% ★★★★★★ Click here to see the full list of 1581 stocks from our Top Global Dividend Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: FibraHotel is a Mexican trust focused on acquiring, developing, and operating hotels in Mexico with a market cap of MX$7.70 billion. Operations: FibraHotel generates revenue from its core activities of acquiring, developing, and managing a portfolio of hotels across Mexico. Dividend Yield: 6.1% FibraHotel's dividend is covered by earnings (40.7% payout ratio) and cash flows (29.9% cash payout ratio), placing it among the top 25% of MX market dividend payers with a yield of 6.15%. However, its dividends have been volatile and declining over the past decade, indicating an unstable track record. Recent Q1 earnings showed slight revenue growth to MX$1.35 billion, though net income decreased to MX$125.12 million from last year's MX$132.49 million. Delve into the full analysis dividend report here for a deeper understanding of FibraHotel. In light of our recent valuation report, it seems possible that FibraHotel is trading beyond its estimated value. Simply Wall St Dividend Rating: ★★★★★☆ Overview: Mitsui Matsushima Holdings Co., Ltd. operates through its subsidiaries in the consumer goods, industrial products, and energy sectors both in Japan and internationally, with a market cap of ¥51.72 billion. Operations: Mitsui Matsushima Holdings Co., Ltd. generates revenue primarily from its Industrial Products segment at ¥29.64 billion and Consumer Goods segment at ¥26.79 billion, with additional contributions from the Finance and Others segment totaling ¥4.21 billion. Dividend Yield: 4.6% Mitsui Matsushima Holdings offers a compelling dividend yield of 4.62%, ranking it in the top quartile among Japanese dividend payers. Despite its attractive yield, the company's dividends have been volatile over the past decade, with periods of significant fluctuation. The current payout ratio is low at 17.3%, suggesting dividends are well-covered by earnings, though cash flow coverage is tighter at an 80.3% cash payout ratio. Recent initiatives include a share buyback and a planned stock split to enhance liquidity and investor accessibility. Take a closer look at Mitsui Matsushima Holdings' potential here in our dividend report. The analysis detailed in our Mitsui Matsushima Holdings valuation report hints at an inflated share price compared to its estimated value. Simply Wall St Dividend Rating: ★★★★★☆ Overview: Shin-Etsu Polymer Co., Ltd. manufactures and sells polyvinyl chloride (PVC) products globally and has a market capitalization of approximately ¥146.41 billion. Operations: Shin-Etsu Polymer Co., Ltd. generates revenue from segments including Electronic Device at ¥24.85 billion, Precision Molding Products at ¥56.02 billion, and Living Environment/Living Materials at ¥22.08 billion. Dividend Yield: 3.1% Shin-Etsu Polymer recently announced a dividend increase to JPY 27.00 per share, up from JPY 24.00 last year, with stable payments over the past decade. The payout ratio stands at a moderate 44.5%, indicating dividends are well-supported by earnings, while the cash payout ratio is higher at 86%. Although its yield of 3.06% is below Japan's top quartile, consistent earnings growth and undervaluation relative to fair value enhance its appeal for dividend investors. Dive into the specifics of Shin-Etsu PolymerLtd here with our thorough dividend report. The valuation report we've compiled suggests that Shin-Etsu PolymerLtd's current price could be quite moderate. Reveal the 1581 hidden gems among our Top Global Dividend Stocks screener with a single click here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BMV:FIHO 12 TSE:1518 and TSE:7970. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
Litecoin Bucks Bearish Trend as ETF Hopes Climb Amid Rising Global Tension
Litecoin clawed back early losses Tuesday to notch a 1.6% daily gain, trading above $84.6 after dipping to $82.69. The rebound came despite choppy markets reacting to heightened tensions surrounding the war between Israel and Iran, which has kept markets on edge, with the odds of a U.S. military action in the region before the end of this month now sitting at 62% according to Polymarket traders. Digital assets, often sensitive to macroeconomic stress, mirrored the jitters. Yet Litecoin showed unusual resilience, bouncing back near a key resistance at $85.6, according to CoinDesk Research's technical analysis data. Traders are watching the SEC's review of spot litecoin ETF applications. Polymarket traders are now pricing in a 76% chance of approval this year. Litecoin posted a 1.6% gain over the 24-hour period, climbing from a low of $82.69 to close at $84.88. The broader market, as measured by the CoinDesk 20 (CD20) index, dropped 0.5% over the same period. Support solidified in the $83.48–$83.57 range, according to CoinDesk Research's technical analysis data model, where buyers stepped in with above-average volume. This buying interest established a floor that helped LTC climb back despite intraday volatility. Resistance emerged at $85.60–$85.67, a zone that was tested twice but not breached. The price action developed an ascending channel, marked by higher lows, a sign of steady bullish momentum even as sellers capped gains. Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
